Man Group plc - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 133 filers reported holding RIGEL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Man Group plc ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$189,172
-3.1%
143,312
+10.1%
0.00%0.0%
Q4 2022$195,168
+550.6%
130,112
+411.1%
0.00%
Q3 2022$30,000
+42.9%
25,456
+131.4%
0.00%
Q3 2019$21,000
-83.2%
11,000
-75.0%
0.00%
-100.0%
Q2 2018$125,00044,0000.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Tamarack Advisers, LP 8,350,000$28,557,0005.86%
Ion Asset Management Ltd. 3,632,132$12,422,0001.43%
CM Management, LLC 500,000$1,710,0001.27%
SECTOR GAMMA AS 1,530,490$5,234,0000.96%
Rhenman & Partners Asset Management AB 1,520,000$5,198,0000.36%
Rock Springs Capital Management LP 4,742,000$16,218,0000.35%
Telemetry Investments, L.L.C. 90,000$308,0000.35%
DAFNA Capital Management LLC 275,500$942,0000.22%
KELLEHER FINANCIAL ADVISORS 100,000$342,0000.22%
Virtus ETF Advisers LLC 91,971$315,0000.13%
View complete list of RIGEL PHARMACEUTICALS INC shareholders